ConductScience.org, home

Paper42663506

Inhibition of miR-301a-3p Expression Promotes Ferroptosis: A New Target for Ferroptosis Treatment in TNBC.

Fu B and 5 others. Breast J, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Inhibition of miR-301a-3p Expression Promotes Ferroptosis: A New Target for Ferroptosis Treatment in TNBC. Papers, record 42663506. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42663506

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhibition of miR-301a-3p Expression Promotes Ferroptosis: A New Target for Ferroptosis Treatment in TNBC.
PubMed
Journal
Breast J
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-08-30
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fu BBaiyanghttps://orcid.org/0000-0001-6704-3724
2Yao YYuan
3Liang WWenlonghttps://orcid.org/0009-0004-2528-5935
4Wang YYao
5Chen XXihttps://orcid.org/0000-0002-5639-8463
6Zhang JJianguohttps://orcid.org/0000-0002-7461-8853

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MicroRNAsMajor topic
FerroptosisMajor topic
Triple Negative Breast NeoplasmsMajor topic
Humans
Female
Cell Proliferation
Cell Line, Tumor
Gene Expression Regulation, Neoplastic
Phospholipid Hydroperoxide Glutathione Peroxidase
Reactive Oxygen Species
Cell Movement
Piperazines
Prognosis

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
81972469National Natural Science Foundation of ChinaPubMedPubMed
YJSCX2025-58HYDHarbin Medical UniversityYJSCX202558PubMedNIH RePORTER

Download CSV of grants

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132106859CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer.Mol Cancer2020https://conductscience.org/library/papers/32106859PubMed
242663506Inhibition of miR-301a-3p Expression Promotes Ferroptosis: A New Target for Ferroptosis Treatment in TNBC.Breast J2026https://conductscience.org/library/papers/42663506PubMed
336938678LINC00460 Facilitates Cell Proliferation and Inhibits Ferroptosis in Breast Cancer Through the miR-320a/MAL2 Axis.Technol Cancer Res Treat2023https://conductscience.org/library/papers/36938678PubMed
434668628CircGFRA1 facilitates the malignant progression of HER-2-positive breast cancer via acting as a sponge of miR-1228 and enhancing AIFM2 expression.J Cell Mol Med2021https://conductscience.org/library/papers/34668628PubMed
536408273Relationship between miRNA and ferroptosis in tumors.Front Pharmacol2022https://conductscience.org/library/papers/36408273PubMed
635741721The History of Early Breast Cancer Treatment.Genes (Basel)2022https://conductscience.org/library/papers/35741721PubMed
736613888Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis.Int J Mol Sci2022https://conductscience.org/library/papers/36613888PubMed
832970954MicroRNA (MiR)-301a-3p regulates the proliferation of esophageal squamous cells via targeting PTEN.Bioengineered2020https://conductscience.org/library/papers/32970954PubMed
937700851TMEM189 as a target gene of MiR-499a-5p regulates breast cancer progression through the ferroptosis pathway.J Clin Biochem Nutr2023https://conductscience.org/library/papers/37700851PubMed
1036257316Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy.Cell Metab2023https://conductscience.org/library/papers/36257316PubMed
1133522578Metformin induces ferroptosis by targeting miR-324-3p/GPX4 axis in breast cancer.Acta Biochim Biophys Sin (Shanghai)2021https://conductscience.org/library/papers/33522578PubMed
1230322806MicroRNA-301a-3p suppressed the progression of hepatocellular carcinoma via targeting VGLL4.Pathol Res Pract2018https://conductscience.org/library/papers/30322806PubMed
1337591453FOXQ1 inhibits breast cancer ferroptosis and progression via the circ_0000643/miR-153/SLC7A11 axis.Exp Cell Res2023https://conductscience.org/library/papers/37591453PubMed
1426640587Hsa-miR-301a-3p Acts as an Oncogene in Laryngeal Squamous Cell Carcinoma via Target Regulation of Smad4.J Cancer2015https://conductscience.org/library/papers/26640587PubMed
1536038913Recent advances in therapeutic strategies for triple-negative breast cancer.J Hematol Oncol2022https://conductscience.org/library/papers/36038913PubMed
1634754128Treatment landscape of triple-negative breast cancer - expanded options, evolving needs.Nat Rev Clin Oncol2022https://conductscience.org/library/papers/34754128PubMed
1734571083SLC7A11/ xCT is a target of miR-5096 and its restoration partially rescues miR-5096-mediated ferroptosis and anti-tumor effects in human breast cancer cells.Cancer Lett2021https://conductscience.org/library/papers/34571083PubMed
1832789480Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical Trial.JAMA Oncol2020https://conductscience.org/library/papers/32789480PubMed
1931762806Cip2a/miR-301a feedback loop promotes cell proliferation and invasion of triple-negative breast cancer.J Cancer2019https://conductscience.org/library/papers/31762806PubMed
2026019136MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.Oncotarget2015https://conductscience.org/library/papers/26019136PubMed

See all 33 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42663506Inhibition of miR-301a-3p Expression Promotes Ferroptosis: A New Target for Ferroptosis Treatment in TNBC.Breast J2026https://conductscience.org/library/papers/42663506

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
GPX42879PubTator's text mininghttps://conductscience.org/library/genes/2879

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42663506

GET https://conductscience.org/api/papers/v1/42663506/references?page=2